Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025
Postcontrast FLAIR MRI Demonstrates Blood-Brain Barrier Dysfunction in PRES
Neurol 72:760-762, Weier,K.,et al, 2009
Post-Transfusion Reversible Posterior Leukoencephalopathy Syndrome with Cerebral Vasoconstriction
Neurol 49:1174-1175, Ito,Y.,et al, 1997
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Dementia in a 58-year-old Woman
Lancet 347:236, Sellal,F.,et al, 1996
Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Epidemiology of Progressive Multifocal Leukoencephalopathy in the US:Analysis of National Mortality & AIDS Surveillance
Neurol 41:1733-1736, Holman,R.C.,et al, 1991
HTLV-I-Associated Myelopathy
NEJM 323:552, Engel,W.K.,et al, 1990